This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Iowa State University Research Foundation Inc., University of Iowa Research Foundation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,427 
1 out of 925 
Years Active: 2020
Title: Innovations in Immunization: The Contributions of Inventor Kathleen A. Ross
Introduction
Kathleen A. Ross, an innovative inventor based in Ames, Iowa, has made significant strides in the field of immunization. With a focus on combating influenza, her pioneering work in the development of a nanovaccine showcases her commitment to advancing public health through scientific research and innovation.
Latest Patents
Kathleen A. Ross holds a patent for an influenza nanovaccine that comprises immunogenic compositions and methods of use. This innovative formulation includes biodegradable or bioerodible polyanhydride nanoparticles made from 1,8-bis(p-carboxyphenoxy)-3,6-dioxaoctane (CPTEG) and 1,6-bis(p-carboxyphenoxy)hexane (CPH) copolymers. The immunogenic composition not only contains an immunogenic protein of the Influenza Virus but also incorporates an adjuvant trapped within the interior of the nanoparticle, along with an excipient. This composition is designed to be administered to individuals, promoting both local and systemic immunity to the Influenza Virus.
Career Highlights
Kathleen A. Ross has had a prominent career, associated with esteemed research institutions. She has worked with Iowa State University Research Foundation, Inc. and the University of Iowa Research Foundation. Her role in these organizations has been pivotal in conducting groundbreaking research and developing innovative solutions to health challenges.
Collaborations
Collaboration has been a key element in Kathleen's career. She has worked alongside notable researchers such as Balaji Narasimhan and Kevin L. Legge, pooling their expertise to enhance the efficacy of immunizations against influenza. This teamwork has contributed to the advancement of vaccine technology, highlighting the importance of collaboration in scientific endeavors.
Conclusion
Kathleen A. Ross's contributions to the field of immunization through her patented influenza nanovaccine underscore her role as a key innovator in public health. Her dedication to research and collaboration has the potential to impact millions by advancing the effectiveness of influenza immunization strategies. As she continues her work, her innovations will remain vital to the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile